Riskpilot← Back to searchSign inGet full accessVicunab AB
ABIn liquidationOrg 5592692379Leasing of intellectual property and similar products, except copyrighted works · NACE 7740Est. 20200 employees
Revenue 2023
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2023
SEK -2K
+91% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK -2K | +91% |
| Total assets | SEK 183K | -11% |
| Equity | SEK 183K | -1% |
| Employees | 0 | — |
Legal name
Vicunab AB
Org number
5592692379
Legal form
Aktiebolag
NACE code
7740 · Leasing of intellectual property and similar products, except copyrighted works
Founded
1 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn likvidatorsuppleanten externa firmatecknaren
Company purpose
Aktiebolaget ska tillverkar, modifierar och licensierar antikroppsbaserade diagnostiska och terapeutiska produkter.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 1 402 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | 1 375 | −22 | — |
| Depreciation & amort. | −0 | — | −0 |
| EBIT | 1 375 | −22 | 0 |
| Net financials | — | 0 | −2 |
| Profit before tax | 1 376 | −22 | −2 |
| Tax | −294 | — | −0 |
| Net profit | 1 082 | −22 | −2 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 1 420 | 205 | 183 |
| Equity | 1 107 | 185 | 183 |
| Long-term debt | 0 | — | 0 |
| Short-term debt | 314 | 20 | 0 |
| Total debt | 314 | 20 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212023
Return on equity
-1.1%
This company
18.4%
Market median
-106% vs market
20212023
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
20212023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JA Liquidator | Liquidator | 2023 | — | — |
HJ Liquidator | Liquidator | 2022 | — | — |
AM External Signatory | External Signatory | 2022 | — | — |
WL Liquidator | Liquidator | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vicunab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Anders Fredrik Lovén | Liquidator | 0 companies |
| Hans Jarl Rutger Arnhult | Liquidator | 0 companies |
| Anna Matilda Sjödin | External Signatory | 0 companies |
| Wendy Lissette Fahlgren | Liquidator | 0 companies |
| Bo Daniel Falk | Board of Directors | 0 companies |
| Gerd Ulla Marina Jonsson | Deputy Board Member | 0 companies |